Starting Insulin Therapy in Type 2 Diabetes: Twice-Daily Biphasic Insulin Aspart 30 Plus Metformin versus Once-Daily Insulin Glargine Plus Glimepiride
Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Authors: P. Kann, T. Wascher, V. Zackova, J. Moeller, J. Medding, A. Szocs, M. Mokan, F. Mrevlje, M. Regulski
Institution: Philipps University of Marburg
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Novo Nordisk
OpenAlex ID: W1996580481
